Caution should be used when interpreting alterations affecting the exon 3 of the BRCA2 gene in breast/ovarian cancer families

J Clin Oncol. 2007 Nov 1;25(31):5035-6; author reply 5036-8. doi: 10.1200/JCO.2007.13.4346.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Breast Neoplasms / genetics*
  • Exons / genetics*
  • Female
  • Genes, BRCA2*
  • Genetic Counseling
  • Genetic Testing
  • Head and Neck Neoplasms / genetics
  • Humans
  • INDEL Mutation
  • Male
  • Middle Aged
  • Ovarian Neoplasms / genetics*